Increased frequency of the apolipoprotein E‐4 isoform in male subjects with multifactorial hypercholesterolemia
暂无分享,去创建一个
[1] F. W. Robertson,et al. Polymorphism at the Apoprotein‐E locus in relation to risk of coronary disease , 1984, Clinical genetics.
[2] K. Berg,et al. Low density lipoprotein receptors in cultured skin fibroblasts from psoriasis patients , 1984, Clinical genetics.
[3] R. Mahley,et al. The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. , 1983, The Journal of biological chemistry.
[4] T. Kita,et al. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. , 1983, The New England journal of medicine.
[5] R. Mahley,et al. Human apolipoprotein E. The complete amino acid sequence. , 1982, The Journal of biological chemistry.
[6] R. Mahley,et al. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. , 1982, The Journal of biological chemistry.
[7] I. Holme,et al. EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.
[8] I. Hjermann,et al. EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE , 1981 .
[9] K. Berg,et al. The apoE polymorphism studied by two‐dimensional, high‐resolution gel electrophoresis of serum , 1981, Clinical genetics.
[10] R. Mahley,et al. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. , 1981, The Journal of biological chemistry.
[11] J. Breslow,et al. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. , 1981, Biochemistry.
[12] R. Mahley,et al. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. , 1980, The Journal of biological chemistry.
[13] I. Hjermann. Smoking and diet intervention in healthy coronary high risk men. Methods and 5-year follow-up of risk factors in a randomized trial. The Oslo study. , 1980, Journal of the Oslo city hospitals.
[14] R. Mahley,et al. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.
[15] N. Anderson,et al. Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing. , 1978, Analytical biochemistry.
[16] N G Anderson,et al. Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. , 1978, Analytical biochemistry.
[17] M. Höök,et al. Glycosaminoglycans and their binding to biological macromolecules. , 1978, Annual review of biochemistry.
[18] N G Anderson,et al. High resolution two-dimensional electrophoresis of human plasma proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Mahley,et al. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.
[20] G. Utermann,et al. Studies on the metabolic defect in Broad‐ß disease (hyperlipoproteinaemia type III) , 1977, Clinical genetics.
[21] J. Goldstein,et al. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans , 1976, Cell.
[22] H. Pownall,et al. The interaction of human plasma glycoaminoglycans with plasma lipoproteins. , 1975 .
[23] P. O’Farrell. High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.
[24] R. Fleischmajer. [Familial hyperlipoproteinemia]. , 1969, Anais brasileiros de dermatologia.